Insiders · PCSA

PCSA insider transactions

Processa Pharmaceuticals Inc. (PCSA) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for PCSA

• 8d
  SEC Form 4 filed by Young David

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 8d
  SEC Form 4 filed by Ng George K

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 8d
  SEC Form 4 filed by Lin Patrick

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 8d
  SEC Form 4 filed by Guy Wendy

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 8d
  SEC Form 4 filed by Bigora Sian

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 8d
  SEC Form 4 filed by Skibsted Russell

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 23d
  SEC Form 4 filed by Neal James R

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 24d
  SEC Form 4 filed by Young David

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 24d
  SEC Form 4 filed by Skibsted Russell

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 24d
  SEC Form 4 filed by Pannu Geraldine

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 24d
  SEC Form 4 filed by Ng George K

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 24d
  SEC Form 4 filed by Lin Patrick

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 24d
  SEC Form 4 filed by Guy Wendy

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 24d
  SEC Form 4 filed by Bigora Sian

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 24d
  SEC Form 4 filed by Baluch Khoso

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 80d
  Pres. Research & Development Young David converted options into 49 shares, increasing direct ownership by 0.56% to 8,752 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 80d
  Chief Business - Strategy Off Lin Patrick converted options into 193 shares, increasing direct ownership by 12% to 1,753 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 80d
  Chief Administrative Officer Guy Wendy converted options into 193 shares, increasing direct ownership by 18% to 1,256 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 80d
  Chief Development Officer Bigora Sian converted options into 249 shares, increasing direct ownership by 18% to 1,604 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 204d
  SEC Form 4 filed by Director Neal James R

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 204d
  SEC Form 4 filed by Director Baluch Khoso

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 204d
  SEC Form 4 filed by Director Pannu Geraldine

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 204d
  SEC Form 4 filed by Director Yorke Justin W

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 204d
  SEC Form 4 filed by Chief Administrative Officer Guy Wendy

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 204d
  SEC Form 4 filed by Chief Business - Strategy Off Lin Patrick

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 204d
  SEC Form 4 filed by Chief Development Officer Bigora Sian

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 204d
  SEC Form 4 filed by Chief Financial Officer Skibsted Russell

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 204d
  SEC Form 4 filed by Pres. Research & Development Young David

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 204d
  SEC Form 4 filed by Chief Executive Officer Ng George K

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 219d
  Amendment: SEC Form 4 filed by Chief Administrative Officer Guy Wendy

  4/A - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 219d
  Amendment: SEC Form 4 filed by Director Yorke Justin W

  4/A - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 219d
  Amendment: SEC Form 4 filed by Pres. Research & Development Young David

  4/A - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 219d
  Amendment: SEC Form 4 filed by Chief Financial Officer Skibsted Russell

  4/A - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 219d
  Amendment: SEC Form 4 filed by Director Pannu Geraldine

  4/A - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 219d
  Amendment: SEC Form 4 filed by Chief Executive Officer Ng George K

  4/A - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 219d
  Amendment: SEC Form 4 filed by Director Neal James R

  4/A - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 219d
  Amendment: SEC Form 4 filed by Chief Business - Strategy Off Lin Patrick

  4/A - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 219d
  Amendment: SEC Form 4 filed by Chief Development Officer Bigora Sian

  4/A - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 219d
  Amendment: SEC Form 4 filed by Director Baluch Khoso

  4/A - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 271d
  SEC Form 4 filed by Chief Administrative Officer Guy Wendy

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 271d
  SEC Form 4 filed by Chief Business - Strategy Off Lin Patrick

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 271d
  SEC Form 4 filed by Chief Development Officer Bigora Sian

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 271d
  SEC Form 4 filed by Chief Financial Officer Skibsted Russell

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 271d
  SEC Form 4 filed by Pres. Research & Development Young David

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 271d
  SEC Form 4 filed by Chief Executive Officer Ng George K

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 271d
  SEC Form 4 filed by Director Neal James R

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 271d
  SEC Form 4 filed by Director Baluch Khoso

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 271d
  SEC Form 4 filed by Director Pannu Geraldine

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 271d
  SEC Form 4 filed by Director Yorke Justin W

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 379d
  Chief Business - Strategy Off Lin Patrick converted options into 14,482 shares and covered exercise/tax liability with 4,814 shares, increasing direct ownership by 33% to 38,727 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 379d
  Chief Development Officer Bigora Sian converted options into 15,059 shares and covered exercise/tax liability with 3,311 shares, increasing direct ownership by 54% to 33,626 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 379d
  Chief Administrative Officer Guy Wendy converted options into 14,482 shares, increasing direct ownership by 122% to 26,339 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 379d
  Pres. Research & Development Young David converted options into 17,272 shares and covered exercise/tax liability with 5,345 shares, increasing direct ownership by 6% to 217,332 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 431d
  Amendment: SEC Form 4 filed by Director Yorke Justin W

  4/A - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 431d
  Amendment: SEC Form 4 filed by Pres. Research & Development Young David

  4/A - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 431d
  Amendment: SEC Form 4 filed by Chief Business - Strategy Off Lin Patrick

  4/A - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 431d
  Amendment: SEC Form 4 filed by Chief Executive Officer Ng George K

  4/A - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 449d
  Director Yorke Justin W bought $9,889 worth of shares (12,400 units at $0.80) (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 451d
  Chief Executive Officer Ng George K bought $69,542 worth of shares (87,200 units at $0.80) (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 451d
  Pres. Research & Development Young David bought $99,289 worth of shares (124,500 units at $0.80), increasing direct ownership by 154% to 205,405 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)